Behçet's disease is a heterogeneous disease that involves variable organ systems. Gastrointestinal Behçet's disease is rare and it generally affects the terminal ileum with propagation toward the cecum and ascending colon. Therefore, esophageal ulcer associated with Behçet's disease has not been reported frequently. We report an unusual case of Behçet's disease associated with both esophageal and pharyngeal ulcers. A 64-year-old man was admitted for an evaluation of pharyngeal and substernal discomfort sustained for 3 months. He had no underlying chronic disease; however, he suffered from recurrent oral and genital ulcers for 20 years and had folliculitis-like skin lesions on the face, scalp and trunk. He was diagnosed with Behçet's disease and gastroesophageal fiberscopy revealed deep ulcers on both the pharynx and upper esophagus. Esophagopharyngeal ulcers were successfully treated with prednisolone, colchicines, dapsone, and sulfasalazine.
Introduction
Behçet's disease (BD) is a heterogeneous disorder with variable involvement of many organ systems, mainly including mucocutaneous, articular, vascular, ophthalmological and gastrointestinal systems. Gastrointestinal BD has been reported to be rare and mainly affects the terminal ileum, cecum, and ascending colon. Esophageal involvement of BD is much rarer and mainly reported in Japan (1) . Among cases of gastrointestinal BD reported in Korea, only 8.7% showed esophageal ulcers (2) .
Gastrointestinal BD has been reported to be difficult to treat and resistant to conventional medication against BD, including 5-aminosalicylic acid (5-ASA), systemic corticosteroids, and immunosuppressive agents (3) . Serious complications such as strictures, bleeding, perforation, or fistulas have been reported especially in esophageal ulcers (2) . In some reports, infliximab, anti-tumor necrosis factor alpha monoclonal antibody, wsa recommended for the treatment of resistant intestinal BD (3, 4) .
We here present an unusual case of BD associated with both esophageal and pharyngeal ulcer treated successfully with prednisolone, colchicines, dapsone, and sulfasalazine.
Case Report
A 64-year-old man was admitted for the evaluation of pharyngeal and substernal discomfort sustained for 3 months. He had no underlying chronic disease including diabetes, hypertension, hepatitis, and tuberculosis. He was non-smoker and has no history of alcohol and drug abuse. He has not been exposed to any irradiation therapy or operation. He has no familial history related to specific diseases including connective tissue disorder, vasculitis, and ulcerative disease of gastrointestinal systems. However, he has suffered from re- 
Discussion
We here present an unusual case of BD associated with esophageal and pharyngeal ulcers which were successfully treated with prednisolone, colchicines, dapsone, and sulfasalazine.
BD is a heterogeneous disorder with variable involvement of many organ systems, mainly including, mucocutaneous, articular, vascular, ophthalmological and gastrointestinal systems.
Gastrointestinal BD has been reported to be rare. The terminal ileum, cecum, and ascending colon are mainly affected by gastrointestinal BD (5) and esophageal involvement covers below 10% of gastrointestinal BD (2). To our knowledge, less than 40 cases have been reported to be associated with esophageal ulcers in English literatures (6) (7) (8) (9) (10) (11) (12) . Most of the cases Esophagopharyngeal Ulcers in Behçet's Disease 313 were reported in Japan.
Gastrointestinal BD is difficult to treat and serious complications such as strictures, bleeding, perforation, or fistulas have been reported especially in esophageal ulcers (2) . Typical symptoms suggesting gastrointestinal BD includes abdominal pain, diarrhea, and melena. Therefore, early detection of esophageal ulcer through gastroesophageal fiberscopy might be delayed in BD patients with simply poor oral intake or substernal chest discomfort.
In this case, ulcers were found in both pharynx and upper esophagus (Figure 1 ), whereas the esophageal ulcers of BD patients locate mainly in the middle or lower esophagus (11) .
Gastrointestinal BD has been reported to be difficult to treat and resistant to conventional medication against BD, including 5-aminosalicylic acid (5-ASA), systemic corticosteroids, and immunosuppressive agents (3). We decided to treat esophagopharyngeal ulcers with empirical medication including prednisolone, colchicin, dapsone and sulfasalazine. Symptom was dramatically improved within a few weeks following the start of medication.
To prevent severe complications including perforation or fistula, it is critical to diagnose gastrointestinal BD earlier and treat
properly. It can be successfully treated with empirical trial of both salazosulfapyridine and steroids.
Summary
Our case suggests following clinical implications. In patients not diagnosed with BD, BD should be considered as the differential diagnosis for newly detected esophageal ulcers, especially when it is recurrent despite of conventional treatment for ulcers.
In case of BD patient, early gastroesophageal fiberscopy should be recommended even for atypical upper gastrointestinal symptoms or signs.
